A detailed history of Verity Asset Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Verity Asset Management, Inc. holds 1,378 shares of LLY stock, worth $1.1 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
1,378
Previous 1,526 9.7%
Holding current value
$1.1 Million
Previous $1.38 Billion 11.61%
% of portfolio
0.46%
Previous 0.54%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$772.14 - $960.02 $114,276 - $142,082
-148 Reduced 9.7%
1,378 $1.22 Billion
Q2 2024

Aug 08, 2024

BUY
$724.87 - $909.04 $574,821 - $720,868
793 Added 108.19%
1,526 $1.38 Billion
Q4 2023

Feb 08, 2024

SELL
$525.19 - $619.13 $9,978 - $11,763
-19 Reduced 2.53%
733 $427 Million
Q3 2023

Nov 22, 2023

BUY
$434.7 - $599.3 $43,470 - $59,929
100 Added 15.34%
752 $404 Million
Q2 2023

Aug 15, 2023

SELL
$350.74 - $468.98 $239,204 - $319,844
-682 Reduced 51.12%
652 $306 Million
Q1 2023

May 24, 2023

BUY
$310.63 - $364.82 $209,364 - $245,888
674 Added 102.12%
1,334 $458 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $3,858 - $4,496
-12 Reduced 1.79%
660 $241 Million
Q3 2022

Nov 15, 2022

SELL
$296.48 - $337.87 $310 Million - $354 Million
-1,046,730 Reduced 99.94%
672 $217 Million
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $246 Million - $305 Million
1,047,402 New
1,047,402 $174,000
Q3 2021

Nov 10, 2021

SELL
$221.6 - $272.71 $301,597 - $371,158
-1,361 Closed
0 $0
Q2 2021

Aug 04, 2021

BUY
$180.55 - $233.54 $245,728 - $317,847
1,361 New
1,361 $312,000
Q2 2020

Nov 13, 2020

SELL
$136.42 - $164.18 $1.25 Million - $1.5 Million
-9,131 Closed
0 $0
Q1 2020

May 18, 2020

BUY
$119.05 - $147.35 $1.09 Million - $1.35 Million
9,131 New
9,131 $1.27 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Verity Asset Management, Inc. Portfolio

Follow Verity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Verity Asset Management, Inc. with notifications on news.